Magnetar Financial LLC Bluebird Bio, Inc. Transaction History

Magnetar Financial LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$16.59 - $33.89 $132,836 - $271,357	-8,007 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$27.5 - $37.92 $220,192 - $303,625	8,007 New	8,007 $346,000
Q2 2020 Aug 14, 2020	SELL	$27.12 - $45.97 $563,553 - $955,256	-20,780 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$26.16 - $63.5 $417,278 - $1.01 Million	15,951 Added 330.32%	20,780 $955,000
Q4 2019 Feb 13, 2020	BUY	$46.96 - $61.67 $71,520 - $93,923	1,523 Added 46.07%	4,829 $424,000
Q1 2018 May 15, 2018	BUY	$105.8 - $150.94 $349,774 - $499,007	3,306 New	3,306 $564,000

150

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $677M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Magnetar Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Magnetar Financial LLC with notifications on news.